Close Menu
    Facebook X (Twitter) Instagram
    Trending
    • Rising Above The Rest: How CUNY York College Is Winning the College Rankings
    • When Campus Safety Becomes a Question of Trust
    • York College: President Wants More Visibility for Athletics
    • CUNY’S Free OMNY Pilot Aims to Ease Transportation Costs for Students
    • NYC Specialized High School Admissions Spark Diversity Debate
    • York’s Community Jam Sessions Bring Musicians Together
    • York College; Professor Dean Explores Irish Tragedy in New Book 
    • Humanities Significantly Defunded at CUNY and Among Universities in the U.S.
    X (Twitter) Instagram YouTube Snapchat SoundCloud
    Thursday, November 19
    • Home
    • News
      • Campus
      • CUNY
    • Arts & Entertainment
    • Cardinal Sports
    • Op Ed
    • Multimedia
      • Radio
      • Television
    • About Us
      • Staff 
      • Contact us
    Home»Lifestyle»Female Viagra Approval Goes Limp
    Lifestyle

    Female Viagra Approval Goes Limp

    Pandoras BoxBy Pandoras BoxMay 6, 2014Updated:May 6, 2014No Comments4 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Reddit Telegram Email
    Share
    Facebook Twitter LinkedIn Pinterest Email
    The female version of Viagra isn't passing the FDA, leaving many suspicious of political and social motivations. (SALON)
    The female version of Viagra isn’t passing the FDA, leaving many suspicious of political and social motivations. (SALON)

    The company seeking to market a female version of Viagra got some deflating news from the Food and Drug Administration (FDA) last month after the agency demanded further testing of the drug before okaying its use in the U.S.

              The FDA announced last month that it wants more data on flibanserin, a non-hormonal drug treatment for premenopausal women suffering from Hypoactive Sexual Desire Disorder (HSDD). FDA officials told the company Sport Pharmaceuticals that it wants further studies to determine how the drug interacts with other medications, affects driving abilities and induces drowsiness.

              Nearly 10 percent of women who took part in earlier trials reported sleepiness while taking the pill. The company now views this as a hurdle in their 15-year research of the drug.

              The approval of the drug became a rallying point for women advocates and some members of Congress, believing regulators are more interested in the approval of enhancement drugs for men than women. The quest for the “female Viagra” has sparked some questions about how much of a libido lift is needed as well as society’s possible disturbance to the sexual desires of women.

              “I do think there’s some type of discrimination considering all the commercials marketing men’s sex drive than females,” said Political Science major Tatiana Sangare.  “Our culture makes it appear men are the only ones who can be pleasured while women are looked at as sex objects.”

              USA Today said the FDA’s request has put the company in a predicament  after receiving a second rejection for the drug. Flibanserin, or the “little pink pill”, was originally created as an antidepressant by Boehringer Ingelheim, a German pharmaceutical company, but due to a number of tests it was found to be ineffective in the treatment of depression.

              In 2006, it was found to help in improving female sex drive. Studies were conducted where 10 to 20 percent of women suffered from HSDD, an absence of sexual desire. Researchers claim this outnumbers the number of men suffering from the disorder.

              “Yeah they deserve to enjoy having sex as much too, but those side effects can hurt you,” said Sangare.

              “Personally, I just don’t understand why women would need that; women are stimulated differently than men,” said the Director of the Health Center Sharon Hawkins.  “Everybody’s different, everybody’s body reacts to different things, I think women need to know what works for them.”

              In 2010, Boehringer decided to cease its attempts in trying to get the drug approved by the FDA, after a panel unanimously rejected its approval. The FDA had questioned the safety and success of the drug after pointing out a number of side effects such as dizziness, nausea and fatigue. The agency also had concerns about taking the drug with alcohol, hormonal contraceptives and other pills.

    Related articles
    • FDA wants more info on female libido pill
    • FDA wants more info on female libido pill
    • Rodgers, Cobb and Driver Doing the Kentucky Derby Parties
    • Here are the Packers at the Kentucky Derby
    Enhanced by Zemanta
    Print Friendly, PDF & Email
    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Previous ArticleNooria Nodrat: Everything You Need to Know
    Next Article York Nursing Program Excels in Recruitment
    Pandoras Box

    Related Posts

    Campus

    York College: President Wants More Visibility for Athletics

    October 30, 2026
    Campus

    CUNY’S Free OMNY Pilot Aims to Ease Transportation Costs for Students

    October 30, 2026
    Arts & Entertainment

    York’s Community Jam Sessions Bring Musicians Together

    October 30, 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Search
    Archives
    • November 2026
    • October 2026
    • October 2025
    • September 2025
    • August 2025
    • June 2025
    • April 2025
    • March 2025
    • February 2025
    • December 2024
    • November 2024
    • October 2024
    • May 2024
    • December 2023
    • October 2023
    • April 2023
    • March 2023
    • February 2023
    • January 2023
    • December 2022
    • November 2022
    • October 2022
    • June 2022
    • May 2022
    • April 2022
    • March 2022
    • February 2022
    • December 2021
    • November 2021
    • October 2021
    • September 2021
    • May 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • December 2020
    • November 2020
    • October 2020
    • September 2020
    • May 2020
    • April 2020
    • March 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • June 2019
    • May 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • August 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • December 2017
    • November 2017
    • October 2017
    • September 2017
    • May 2017
    • April 2017
    • March 2017
    • February 2017
    • December 2016
    • November 2016
    • October 2016
    • September 2016
    • May 2016
    • April 2016
    • March 2016
    • January 2016
    • December 2015
    • November 2015
    • October 2015
    • September 2015
    • May 2015
    • April 2015
    • March 2015
    • February 2015
    • January 2015
    • December 2014
    • November 2014
    • October 2014
    • September 2014
    • May 2014
    • April 2014
    • March 2014
    • February 2014
    Most Popular

    Traffic in Jamaica Will Worsen With The Coming of New York Islanders

    October 12, 2018

    York College Alum Dedicates Book to Journalism Professor

    April 29, 2016

    CUNYFirst Still Draws Resentment from Students, Admins Defend Software

    October 29, 2014
    News

    Rising Above The Rest: How CUNY York College Is Winning the College Rankings

    November 12, 2026

    When Campus Safety Becomes a Question of Trust

    November 10, 2026

    York College: President Wants More Visibility for Athletics

    October 30, 2026
    CAMPUS

    Rising Above The Rest: How CUNY York College Is Winning the College Rankings

    November 12, 2026

    When Campus Safety Becomes a Question of Trust

    November 10, 2026

    York College: President Wants More Visibility for Athletics

    October 30, 2026
    X (Twitter) Instagram YouTube Snapchat SoundCloud
    Copyright © 2024 Yorkpbnews.net All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.

    Loading Comments...